Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Costco says cooperating with DEA probe on controlled substances

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/17/2013 | 12:05am CEST

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected.

The DEA revoked the controlled substance licenses of two CVS Caremark Corp (>> CVS Caremark Corporation) drugstores in Florida in 2012, and earlier this year Walgreen Co (>> Walgreen Company) reached a record $80 million settlement with the agency to resolve allegations that its negligence in record-keeping and dispensing allowed highly addictive drugs to reach abusers and be sold illegally.

Costco announced its plans to cooperate with the DEA's subpoenas and administrative inspection warrants in a filing with the U.S. Securities and Exchange Commission on Wednesday. It said the matter concerned its "fulfillment of prescriptions related to controlled substances and related practices."

Additional details were not provided, and company representatives declined to comment beyond what was included in the regulatory filing.

(Reporting by Jessica Wohl in Chicago; Editing by Leslie Adler and Bob Burgdorfer)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
07/28DJWALGREENS BOOTS ALLIANCE : to Shut Down to Shut Down to Shut Down
07/28DJWALGREENS BOOTS ALLIANCE : to Shut Down Drugstore.com, Focus on Own Website
07/28 WALGREENS BOOTS ALLIANCE, INC. : Other Events (form 8-K)
07/28 INTERRA RESOURCES : Walgreens exec Steve Pemberton is champion of diverse workpl..
07/28 INTERRA RESOURCES : Walgreens exec is champion of diverse workplaces
07/27 INTERRA RESOURCES : Walgreens exec is champion of diverse workplaces
07/26 WALGREENS BOOTS ALLIANCE, INC. : Other Events, Financial Statements and Exhibits..
07/26 WALGREENS BOOTS ALLIANCE : Announces Secondary Common Stock Offering
07/25 WALGREENS : Safe Medication Disposal Kiosks Now Available at Nearly 300 Pharmaci..
07/21 WALGREENS BOOTS ALLIANCE : Increases Quarterly Dividend
More news
Sector news : Drug Retailers - NEC
07/29DJCELESIO : Germany's Celesio Ordered to Sell Pharmacies for Sainsbury Deal Approv..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/27DJMCKESSON : Profit Declines
07/25DJEXPRESS SCRIPTS : Narrows Annual Guidance
07/25DJEXPRESS SCRIPTS : Narrows Annual Guidance
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2016 117 906 M
EBIT 2016 6 949 M
Net income 2016 4 038 M
Debt 2016 10 257 M
Yield 2016 1,81%
P/E ratio 2016 21,00
P/E ratio 2017 17,15
EV / Sales 2016 0,81x
EV / Sales 2017 0,78x
Capitalization 85 774 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 92,8 $
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%85 774
CVS HEALTH CORP-5.17%99 583
WALGREENS BOOTS ALLIAN..-6.93%85 774
EXPRESS SCRIPTS HOLDIN..-12.97%47 941
MCKESSON CORPORATION-1.35%43 913
CARDINAL HEALTH INC-6.35%27 238
More Results